Recalls / Active ingredient / Lacosamide
Lacosamide
6 FDA drug recalls involving the active ingredient “Lacosamide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-03-13 | Class II | Lacosamide Tablets, 100mg , 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pitha | Glenmark Pharmaceuticals Inc., USA |
| 2025-03-13 | Class II | Lacosamide Tablets 150mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithamp | Glenmark Pharmaceuticals Inc., USA |
| 2025-03-13 | Class II | Lacosamide Tablets 200mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithamp | Glenmark Pharmaceuticals Inc., USA |
| 2025-03-13 | Class II | Lacosamide Tablets, 50mg, 60-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pitham | Glenmark Pharmaceuticals Inc., USA |
| 2022-12-06 | Class III | Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharm | Camber Pharmaceuticals, Inc |
| 2021-03-15 | Class II | VIMPAT (lacosamide) Tablets, 200mg, 60-count bottle, Rx Only, Manufactured for: UCB, Inc. Smyrna, GA 30080, N | Cardinal Health Inc. |